Momo Medical

+85%

est. 2Y upside i

HealthcareSeries A

We help nurses in nursing homes to be 30% more effective

Rank

#704

Sector

Health Technology

Est. Liquidity

~5Y

Data Quality

Data: Medium

Momo Medical offers moderate upside potential (85% expected) over 2 years, but high dilution and incumbent competition weigh on returns.

Last updated: July 3, 2026

Bull (20%)+230%

Category leadership drives multiple expansion to 8x forward revenue; exit value reaches $139M. Net of estimated 20% dilution, upside is 230%.

Base (35%)+114%

Multiple converges to public comp mid-range of 5x; exit value $87M. After 20% dilution, net upside 114%.

Bear (45%)-3%

Incumbent competition compresses multiple to 2x; exit value $35M barely above entry. Post-dilution, slight loss of 2.5%.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

Funding Intensity

25%

Total funding of $9.02M represents 25% of estimated entry valuation, indicating significant preference overhang.

Dilution Risk

high

With high cash burn and no profitability, a dilutive raise is likely within 12-18 months, reducing equity value by ~20%.

Secondary Liquidity

none

No secondary market observed; shares are illiquid until a liquidity event.

Questions to Ask at the Interview

Strategic questions based on Momo Medical's data — designed to show you've done your homework.

1
“How does Momo Medical defend against incumbent smart bed manufacturers entering remote monitoring?”
2
“What is the unit economics (LTV/CAC) for the BedSense subscription, and how do churn rates compare?”
3
“Given the Series A was 2 years ago and runway is tight, what is the expected next round and its dilutive impact?”

Our model estimates +85% upside. What do you think?

Anonymous. Do not share material non-public information.

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.